R1 RCM Acquires Acclara from Providence

December 6, 2023

R1 RCM Inc. has entered into a definitive agreement to acquire Acclara from Providence for $675 million in cash plus warrants to purchase 12.2 million shares of R1. The deal includes a 10-year revenue cycle management agreement whereby Acclara and Providence will partner with R1, expanding R1's scale, capabilities, and long-term revenue opportunities in healthcare revenue cycle management.

Buyers
R1 RCM Inc.
Targets
Acclara
Sellers
Providence
Location
Texas, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.